We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
2101
Ares Capital
ARCC
$13.6B
$14.8K ﹤0.01%
731
-13,484
-95% -$272K
FSLY icon
2102
Fastly Inc
FSLY
$3.14B
$14.7K ﹤0.01%
1,448
CEVA icon
2103
CEVA Inc
CEVA
$980M
$14.7K ﹤0.01%
681
ATEC icon
2104
Alphatec Holdings
ATEC
$1.33B
$14.6K ﹤0.01%
696
-121
-15% -$2.24K
OSG
2105
Octave Specialty Group
OSG
$258M
$14.6K ﹤0.01%
1,878
-605
-24% -$5.17K
SENEA icon
2106
Seneca Foods Class A
SENEA
$1.13B
$14.6K ﹤0.01%
132
UAA icon
2107
Under Armour
UAA
$3.02B
$14.5K ﹤0.01%
2,915
-26,141
-90% -$121K
HOG icon
2108
Harley-Davidson
HOG
$2.61B
$14.4K ﹤0.01%
701
-297
-30% -$7.3K
PCRX icon
2109
Pacira BioSciences
PCRX
$1.04B
$14.4K ﹤0.01%
555
JAZZ icon
2110
Jazz Pharmaceuticals
JAZZ
$16B
$14.3K ﹤0.01%
84
ZGN icon
2111
Zegna
ZGN
$4B
$14.3K ﹤0.01%
1,391
+1,144
+463% +$11.7K
ASH icon
2112
Ashland
ASH
$3.04B
$14.2K ﹤0.01%
242
-423
-64% -$22.4K
TMP icon
2113
Tompkins Financial
TMP
$1.43B
$14.2K ﹤0.01%
196
-52
-21% -$3.56K
STKL
2114
DELISTED
SunOpta
STKL
$14.2K ﹤0.01%
3,724
-2,403
-39% -$10.9K
BLBD icon
2115
Blue Bird Corp
BLBD
$2.41B
$14.1K ﹤0.01%
299
SGHC icon
2116
SGHC Ltd
SGHC
$7.45B
$14K ﹤0.01%
1,171
JBLU icon
2117
JetBlue
JBLU
$2.02B
$13.8K ﹤0.01%
3,035
-2,478
-45% -$11.3K
SCL icon
2118
Stepan Co
SCL
$1.31B
$13.7K ﹤0.01%
290
-1,004
-78% -$46K
NEWT icon
2119
NewtekOne
NEWT
$415M
$13.7K ﹤0.01%
1,206
+1,110
+1,156% +$12.1K
ROAD icon
2120
Construction Partners
ROAD
$5.94B
$13.7K ﹤0.01%
126
HRTG icon
2121
Heritage Insurance Holdings
HRTG
$864M
$13.5K ﹤0.01%
462
REPX icon
2122
Riley Exploration Permian
REPX
$740M
$13.5K ﹤0.01%
511
+22
+4% +$585
TRS icon
2123
TriMas Corp
TRS
$1.45B
$13.4K ﹤0.01%
378
-4
-1% -$140
JOBY icon
2124
Joby Aviation
JOBY
$7.25B
$13.4K ﹤0.01%
1,014
+53
+6% +$813
CLLS
2125
Cellectis
CLLS
$291M
$13.4K ﹤0.01%
+2,761
New +$11.5K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.